Uni Rokkan Centre, Bergen, Norway.
Soc Sci Med. 2012 Dec;75(11):1964-73. doi: 10.1016/j.socscimed.2012.08.005. Epub 2012 Aug 16.
Available literature provides little insight into medical doctors' prescription choices when they are required to make complex trade-offs between different concerns such as treatment effect, costs, and patient preferences simultaneously. This study investigates this issue. It is based on a Discrete Choice Experiment (DCE) conducted with 571 Norwegian doctors, where the DCE captures preferences for medications described along five dimensions important for both clinical decision-making and prioritisation in the health sector. Although effectiveness is the most important determinant of choice in our study, doctors also put considerable weight on patients' preferences and on avoiding high total costs. The probability of choosing a particular medication increases when doctors have a positive experience with the medication. GPs value high clinical effectiveness less than hospital consultants do. They are also less concerned with patient preferences. For both groups of doctors it turns out that they are willing to make difficult trade-offs between attributes they are often assumed not to be willing to compromise on, like effectiveness or patient preferences, and cost measures - given that they have proper information about these attributes.
现有文献几乎没有深入探讨当医生需要在治疗效果、成本和患者偏好等不同关注点之间进行复杂权衡时的处方选择。本研究对此进行了调查。该研究基于对 571 名挪威医生进行的离散选择实验 (DCE),DCE 捕捉了对药物的偏好,这些药物沿着对临床决策和卫生部门优先级制定都很重要的五个维度进行描述。尽管在我们的研究中,有效性是选择的最重要决定因素,但医生也非常重视患者的偏好和避免高额总成本。当医生对药物有积极的体验时,选择特定药物的概率会增加。全科医生对高临床疗效的重视程度低于医院顾问。他们也不太关注患者的偏好。对于这两组医生来说,事实证明,只要他们对这些属性有适当的了解,他们愿意在他们通常被认为不愿意妥协的属性(如疗效或患者偏好)和成本措施之间进行艰难的权衡。